Artiva Biotherapeutics Inc. Common Stock (ARTV)
Stock · NASDAQ · Health Care
$11.09as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$9.24
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Fundamentals
- Market cap
- $265.95M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- —
- Avg. volume
- —
How Artiva Biotherapeutics Inc. Common Stock Makes Money
Where the revenue actually goes — FY2024 annual results
Source: 10-K filed Mar 24, 2025 · via SEC EDGAR / Finnhub
Artiva Biotherapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- ARTVArtiva Biotherapeutics Inc. Common Stock$11.09▼ 7.12%Market cap $265.95MP/E —
- EDITEditas Medicine Inc. Common Stock$3.15▼ 4.55%Market cap $259.45MP/E —$1.66$4.54
- AVXLAnavex Life Sciences Corp. Common Stock$2.98▼ 4.79%Market cap $273.38MP/E —$2.26$10.4
- LCTXLineage Cell Therapeutics Inc. Common Stock$1.11▼ 4.31%Market cap $276.72MP/E —$1$2.09
- SRZNSurrozen Inc. Common Stock$22.42▼ 6.62%Market cap $252.87MP/E —$10.73$35
- SABSSAB Biotherapeutics Inc. Common Stock$3.79▼ 3.56%Market cap $289.80MP/E 26.94$1.85$5.15
- NMRANeumora Therapeutics Inc. Common Stock$1.38▼ 6.76%Market cap $303.87MP/E —$0.83015$3.65
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ARTV Artiva Biotherapeutics Inc. Common Stock | $265.95M | — | $11.09 | ▼ 7.12% | |
| EDIT Editas Medicine Inc. Common Stock | $259.45M | — | $3.15 | ▼ 4.55% | $1.66$4.54 |
| AVXL Anavex Life Sciences Corp. Common Stock | $273.38M | — | $2.98 | ▼ 4.79% | $2.26$10.4 |
| LCTX Lineage Cell Therapeutics Inc. Common Stock | $276.72M | — | $1.11 | ▼ 4.31% | $1$2.09 |
| SRZN Surrozen Inc. Common Stock | $252.87M | — | $22.42 | ▼ 6.62% | $10.73$35 |
| SABS SAB Biotherapeutics Inc. Common Stock | $289.80M | 26.94 | $3.79 | ▼ 3.56% | $1.85$5.15 |
| NMRA Neumora Therapeutics Inc. Common Stock | $303.87M | — | $1.38 | ▼ 6.76% | $0.83015$3.65 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Artiva Biotherapeutics: Targeting A Potentially Lucrative NicheSeekingAlpha · 8/18/2026
- Artiva Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business HighlightsYahoo · 8/6/2026
- Artiva Biotherapeutics Files Prospectus To Offer Up To $400M In SecuritiesBenzinga · 8/6/2026
Insider Activity
Insider Actions →Acquired
1.62M
Disposed
0
- RA CAPITAL MANAGEMENT, L.P. · July 31, 2026 · Buy24.9K @ $9.93
- RA CAPITAL MANAGEMENT, L.P. · July 29, 2026 · Buy20.8K @ $9.99
- RA CAPITAL MANAGEMENT, L.P. · July 24, 2026 · Buy41.3K @ $9.99
- RA CAPITAL MANAGEMENT, L.P. · July 23, 2026 · Buy59.9K @ $9.96
- RA CAPITAL MANAGEMENT, L.P. · July 22, 2026 · Buy84.1K @ $9.93
- RA CAPITAL MANAGEMENT, L.P. · July 21, 2026 · Buy120.6K @ $9.55
- RA CAPITAL MANAGEMENT, L.P. · July 17, 2026 · Buy7.9K @ $8.95
- RA CAPITAL MANAGEMENT, L.P. · July 16, 2026 · Buy152.5K @ $8.93
- RA CAPITAL MANAGEMENT, L.P. · July 13, 2026 · Buy6.5K @ $8.94
- RA CAPITAL MANAGEMENT, L.P. · July 13, 2026 · Buy6.6K @ $8.94
- RA CAPITAL MANAGEMENT, L.P. · July 10, 2026 · Buy15.1K @ $8.97
- RA Capital Healthcare Fund LP · June 16, 2026 · Buy124.9K @ $8.89
- RA Capital Healthcare Fund LP · June 15, 2026 · Buy15.4K @ $8.99
- RA Capital Healthcare Fund LP · June 12, 2026 · Buy391.0K @ $8.57
- RA Capital Healthcare Fund LP · June 11, 2026 · Buy548.6K @ $7.91
Institutional Ownership
March 31, 2026
- Total shares held
- 16.80M
- Total value held
- $108.21M
- Institutional holders
- 38
Top holders this quarter
- Unknown9.85M
- Unknown2.35M
- Unknown1.61M
- Unknown531.3K
- Unknown520.3K
- Unknown299.3K
- Unknown213.4K
- Unknown207.7K
- Unknown194.1K
- Unknown146.4K
See the full, filterable feed with live charts on the MarketWall dashboard.